- Previous Close
0.680 - Open
0.680 - Bid 0.680 x --
- Ask 0.690 x --
- Day's Range
0.680 - 0.700 - 52 Week Range
0.530 - 2.180 - Volume
254,000 - Avg. Volume
926,823 - Market Cap (intraday)
799.17M - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
-- - EPS (TTM)
-0.010 - Earnings Date --
- Forward Dividend & Yield 0.01 (1.47%)
- Ex-Dividend Date Dec 30, 2024
- 1y Target Est
3.05
EC Healthcare, an investment holding company, engages in the provision of medical and healthcare services in Hong Kong, Macau, and the People's Republic of China. The company operates through Medical, Aesthetic Medical and Beauty and Wellness, Veterinary and Other segments. It also offers quasi-medical, beauty and wellness, medical imaging, medical surgery, aesthetic medical beauty, aesthetic medical, dental, eye and hair treatment, vaccine, and chiropractic services. In addition, the company provides administrative, management, laboratory testing, marketing, and travel agency services; sells beauty and skincare products; operates in healthcare machines and property investment holding businesses; and provides multi-channel networking and related services, and veterinary services. Further, it offers rehabilitation and cancer diagnosis services, as well as involved in leasing and hospital related services, and owns trademarks. EC Healthcare offers products and services primarily under private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Quarry Bay, Hong Kong.
www.echealthcare.com2,872
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 2138.HK
View MorePerformance Overview: 2138.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2138.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2138.HK
View MoreValuation Measures
Market Cap
799.17M
Enterprise Value
1.47B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.19
Price/Book (mrq)
0.40
Enterprise Value/Revenue
0.35
Enterprise Value/EBITDA
1.94
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.28%
Return on Assets (ttm)
1.49%
Return on Equity (ttm)
1.40%
Revenue (ttm)
4.15B
Net Income Avi to Common (ttm)
-11.5M
Diluted EPS (ttm)
-0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
866.42M
Total Debt/Equity (mrq)
59.19%
Levered Free Cash Flow (ttm)
253.79M